Hospitals that serve the more vulnerable population perform worse with their readmission rate following cancer surgery, and the subsequent penalties that they face can further strain the hospital’s already burdened finances.
Hospitals that serve the more vulnerable population perform worse with their readmission rate, and the subsequent penalties that they face can further strain the hospital’s already burdened finances. These are the conclusions from a new study, published online in the Journal of the American College of Surgeons, which evaluated the readmission rate in patients following cancer surgery.
Nearly 110,900 patients who underwent complex surgeries for their cancer—between January 1, 2004, and September 30, 2011, in California—were identified. Vulnerable hospitals were defined as either self-identified safety net hospitals (SNH) or hospitals with high percentage of Medicaid patients (high Medicaid hospitals, HMH). Of the 355 hospitals that were included in the analysis, 13 were SNH and 31 were HMH. After adjusting for Hospital Readmissions Reduction Program (HRRP) variables, the study found that:
Further, with respect to patient demographics, patients who were admitted for surgeries in vulnerable hospitals, compared with non-vulnerable hospitals, were:
Additionally, HMH hospitals saw a significantly greater number of patients of Hispanic origin enrolled.
While multiple factors can influence readmission rates, socioeconomic and hospital characteristics bear significant weight. Penalizing hospitals for high readmission rates without understanding these influences can add significant stress on a hospital’s resources. A report released by Kaiser Health News last year found that following inception of the HRRP, readmission rates dropped overall, but 1 in 5 hospitalized Medicare patients were still readmitted to the hospital within 30 days. These numbers underscore the vulnerable nature of hospitals that serve these patients.
“Different hospitals have different patient mixes, and if that is not factored in, HRRP reductions in payment may further marginalize financially vulnerable hospitals,” said corresponding study author Waddah B. Al-Refaie, MD, FACS, chief of surgical oncology, MedStar Georgetown University Hospital, in a press release.
Reference
Hong Y, Zheng C, Hechenbleikner E, et al. Vulnerable hospitals and cancer surgery readmissions: Insights into the unintended consequences of the Patient Protection and Affordable Care Act [published online May 31, 2016]. J Am Coll Surg. doi:http://dx.doi.org/10.1016/j.jamcollsurg.2016.04.042.
Review Emphasizes Potential Infection Risks With BTK Inhibitors
November 2nd 2024Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have significantly increased risks of infection, especially in the upper respiratory tract.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More